Docoh
Loading...

GOSS Gossamer Bio

GRANT
Utility
Solid forms of(Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl) benzoic acid
7 Sep 21
The present invention provides new salts and crystalline forms of leukadherin LA1 [(Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid] according to Formula I.
Antonio J. Barbosa
Filed: 5 Nov 19
APP
Utility
DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE and Related Compounds and Their Use In Treating Medical Conditions
13 May 21
The invention provides dihydroisoquinoline-2(1H)-carboxamide and related compounds, pharmaceutical compositions, and their use in the treatment of medical conditions, such as cancer, and in inhibiting HPK1 activity.
Thomas Daniel Aicher, Donald J. Skalitzky, Peter L. Toogood, Chad A. Vanhuis
Filed: 11 Apr 19
APP
Utility
Solid Forms OF(Z)-4-(5-((3-BENZYL-4-OXO-2-THIOXOTHIAZOLIDIN-5-YLIDENE)METHYL)FURAN-2-YL)BENZOIC Acid
7 Oct 20
The present invention provides new salts and crystalline forms of leukadherin LA1 [(Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid] according to Formula I.
Antonio J. Barbosa
Filed: 4 Nov 19
GRANT
Utility
Solid forms of (Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid
27 Jul 20
The present invention provides new salts and crystalline forms of leukadherin LA1 [(Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid] according to Formula I.
Antonio J. Barbosa
Filed: 9 Jun 16
APP
Utility
Heterocyclic Integrin Agonists
22 Apr 20
The present invention provides polycyclic oxothioxoimidazolidines, dioxoimidazolines, oxothioxooxazolidines, dioxooxazolidines, and related compounds, which are useful as integrin agonists.
Antonio J. Barbosa
Filed: 27 Dec 17
GRANT
Utility
Quinoline derivative in crystal form
20 Apr 20
Crystals of [8-chloro-3-(4-chlorobenzyl)-4-difluoromethoxy-2-ethylquinolin-5-yloxy]acetic acid L-lysine salt, i.e., a crystal A which has peaks at diffraction angles 2θ=6.0°, 10.0°, 10.7°, 12.1°, 18.4°, 19.2° and 20.1° in powder X-ray diffraction spectra and a crystal B which has peaks at diffraction angles 2θ=6.0°, 11.7°, 12.4°, 15.2°, 16.4°, 20.3° and 22.6° in powder X-ray diffraction spectra.
Donald John Daley, John Gary Montana, George Hynd, Mitsuru Teramoto, Takahiro Ito
Filed: 24 Jul 19
  • 1
Patents are sorted by USPTO publication date, most recent first